UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 20, 2020
BRUNSWICK CORPORATION
(Exact Name of Registrant Specified in Charter)
|
| | | | |
| |
| | | | | |
| Delaware | | 001-01043 | | 36-0848180 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
|
| | | |
| |
| 26125 N. Riverwoods Blvd., Suite 500 | |
60045-3420 |
| Illinois | |
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (847) 735-4700
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
| | | | |
| Securities registered pursuant to Section 12(b) of the Act: |
| Title of Each Class | | Trading Symbol(s) | | Name of Each Exchange on Which Registered |
| Common stock, par value $0.75 per share | | BC | | New York Stock Exchange |
| | | Chicago Stock Exchange |
| 6.500% Senior Notes due 2048 | | BC-A | | New York Stock Exchange |
| 6.625% Senior Notes due 2049 | | BC-B | | New York Stock Exchange |
| 6.375% Senior Notes due 2049 | | BC-C | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. Regulation FD Disclosure.
On March 20, 2020, Brunswick Corporation (the “Company”) issued a press release to provide an update on the global operational and business impacts related to the COVID-19 pandemic. The Company announced that it will temporarily suspend production, beginning March 23, at certain of its propulsion and boat facilities over the next few weeks in response to the impact of COVID-19. A copy of the press release is furnished as Exhibit 99.1.
In addition, this situation is constantly changing, and the Company continues to work with its local teams on mitigating the operational and business impacts. At this time, neither the duration nor scope of the disruption caused by COVID-19 can be predicted. Consequently, the financial impact to the Company’s results and future financial or operational performance, including its fiscal 2020 guidance, cannot be reasonably estimated. The Company will provide an update during its first quarter earnings call.
The information in this report and the exhibits attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
|
| |
| Exhibit No. | Description of Exhibit |
| |
| 104 | The cover page from this Current Report on Form 8-K, embedded within and formatted in Inline XBRL. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | |
| | | |
| | | |
| | BRUNSWICK CORPORATION |
| | | |
| Dated: March 20, 2020 | By: | /s/ CHRISTOPHER F. DEKKER |
| | Name: | Christopher F. Dekker |
| | Title: | Vice President, General Counsel and Secretary |
